Alpha 2.0
Login Register
» Articles » PMID: 15086964

Bisphosphonates to Prevent Skeletal Morbidity in Patients with Lung Cancer with Bone Metastases

Overview
Journal Clin Lung Cancer
Publisher Elsevier
Specialties Oncology
Pulmonary Medicine
Date 2004 Apr 17
PMID 15086964
Citations 11
Authors
Nancy Price
Affiliations
Soon will be listed here.
Citing Articles

Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.

Izadiyan Z, Misran M, Kalantari K, Webster T, Kia P, Basrowi N Int J Nanomedicine. 2025; 20:1213-1262.

PMID: 39911259 PMC: 11794392. DOI: 10.2147/IJN.S488961.

Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with -mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.

Tanaka I, Hori K, Koyama J, Gen S, Morise M, Kodama Y Ther Adv Med Oncol. 2024; 16:17588359241303090.

PMID: 39712073 PMC: 11662391. DOI: 10.1177/17588359241303090.

Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis.

Lorange J, Ramirez Garcia Luna J, Grou-Boileau F, Rosenzweig D, Weber M, Akoury E J Bone Oncol. 2023; 39:100470.

PMID: 36860585 PMC: 9969300. DOI: 10.1016/j.jbo.2023.100470.

Retrospective study of EGFR-mutant lung adenocarcinoma with bone metastatic clinical features.

Gu L, Gong T, Ma Q, Zhong D Cancer Rep (Hoboken). 2022; 6(1):e1628.

PMID: 35614541 PMC: 9875678. DOI: 10.1002/cnr2.1628.

Clinical analysis of patients with skeletal metastasis of lung cancer.

Cho Y, Cho Y, Kim S, Shin K, Jung S, Kim H BMC Cancer. 2019; 19(1):303.

PMID: 30943924 PMC: 6446278. DOI: 10.1186/s12885-019-5534-3.